Pathophysiology of right ventricular (RV) failure.

Slides:

Advertisements

Similar presentations

Left Ventricular Pressure-Volume Loops

Advertisements

Lecture:10 Contractility, Stroke volume and Heart Failure

Hemodynamic Monitoring

Cardiac Output: And Influencing Factors. Cardiac Output Amount of blood pumped out by each ventricle in 1 min CO = HR x SV.

Congestive Heart Failure

Ventricular Pressure loop

1 Cardiac Pathophysiology Part B. 2 Heart Failure The heart as a pump is insufficient to meet the metabolic requirements of tissues. Can be due to: –

Cardiac Output When the heart contracts Cardiac Vocabulary Contractility: Contractility is the intrinsic ability of cardiac muscle to develop force for.

Frank-Starling Mechanism

Position of the Heart and Associated Structures Coronary trivia Pumps blood through 60,000 miles of blood vessels Pumps about 3,600 gal per day 2.6 million.

1 Chapter 23 and 24 Valvular problems and circulatory shock.

Physiology of Ventricular Function Dr. Chris Glover Interventional Cardiology Director of Education University of Ottawa Heart Institute January 12, 2015.

 By the end of this lecture the students are expected to:  Explain how cardiac contractility affect stroke volume.  Calculate CO using Fick’s principle.

The cardiac cycle Ventricular filling the diastole refers to the period of the cardiac cycle during which the ventricles are filling with blood the systole.

© 2015 Pearson Education, Inc. Figure Pressure and Volume Relationships in the Cardiac Cycle. Aorta Electro- cardiogram (ECG) QRS complex P T ONE.

Author(s): Louis D’Alecy, D.M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons.

Heart Failure NURS 241 Chapter 35 (p.797).

Factors that effect EDV and ESV

Cardiac Output And Hemodynamic Measurements

Cardiac Physiology Class 1.

The Cardiovascular System

Chapter 20, part 4 The Heart.

The key pathways and classes of drugs that have been approved for the treatment of pulmonary arterial hypertension. The key pathways and classes of drugs.

Physiological changes in pulmonary arterial hypertension (PAH) patients which occur in response to pregnancy. Physiological changes in pulmonary arterial.

Theoretic Impact of Infarct Compliance on Left Ventricular Function

a) Normal parasternal long-axis view.

A 45-year-old with pulmonary hypertension

Severe pulmonary hypertension (PH) in interstitial lung disease (ILD) stepwise composite echocardiographic score. Severe pulmonary hypertension (PH) in.

Michael Argenziano, MDa, David A

Factors affecting cardiac output

Schematic diagram showing as yet unexplored pathophysiological mechanisms in pulmonary arterial hypertension (PAH). Schematic diagram showing as yet unexplored.

Key pathways involved in the pathogenesis of pulmonary arterial hypertension: a) endothelin (ET) pathway; b) nitric oxide pathway; and c) prostacyclin.

Schematic representation of breathing levels during positive expiratory pressure in an obstructed patient. Schematic representation of breathing levels.

Timeline of approval of therapies for pulmonary arterial hypertension.

Inclusion characteristics of a) previously diagnosed and b) newly diagnosed pulmonary arterial hypertension (PAH) patients enrolled in REVEAL. PVR: pulmonary.

An algorithm for the early diagnosis of pulmonary arterial hypertension in systemic sclerosis. An algorithm for the early diagnosis of pulmonary arterial.

Computed tomography coronary angiogram from a 43-year-old female patient with pulmonary arterial hypertension, showing compression of the left coronary.

Reverse remodelling of left and right cavities under specific therapy in a patient with severe idiopathic pulmonary arterial hypertension. a) Before specific.

Chapter 17: Function of the Heart

Effect of intravenous furosemide in a pulmonary arterial hypertension patient admitted with overt right heart failure documented by echo-Doppler of the.

dr. Sri Lestari Sulistyo Rini, MSc

Heart Topics Location of the Heart Chambers of the Heart Heart Valves

Right ventricular (RV) pressure–volume loops at decreasing venous return in a patient with a) systemic sclerosis-associated pulmonary arterial hypertension.

A) Measurement of the right atrial a) area and b) long axis for calculation of right atrial volume. c) Measurement of the left ventricular eccentricity.

A pump function graph demonstrating mean right ventricular pressure as a function of stroke volume (SV). A pump function graph demonstrating mean right.

A) Levels of nitrosothiols in breath condensate in normal healthy smokers and patients with chronic obstructive pulmonary disease (COPD). b) Increased.

Haemodynamic response to exercise in a) normal subjects and b) Fontan patients. Haemodynamic response to exercise in a) normal subjects and b) Fontan patients.

Prevalence of pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD) according to defect. Prevalence of pulmonary arterial.

Pulmonary arterial hypertension specific medication use at enrolment among previously diagnosed patients. 184 (7%) of patients were not on a prostaglandin,

Patrick O’Gara et al. JIMG 2008;1:

Cardiac magnetic resonance imaging of the heart in a patient with pulmonary arterial hypertension. a) Short axis image. #: dilated right ventricle; ¶:

Kaplan–Meier survival curves for baseline cardiac magnetic resonance imaging variables according to the median value in patients with pulmonary hypertension.

Pathophysiology of obesity hypoventilation syndrome (OHS).

Definition of pulmonary hypertension (PH) associated with left heart disease. mPAP: mean pulmonary arterial pressure; PAWP: pulmonary artery wedge pressure;

Example scans for a typical patient with operable chronic thromboembolic pulmonary hypertension. a) Perfusion (Q′) and b) ventilation (V′) lung scans.

Mean pulmonary arterial pressure (Ppa) as a function of cardiac output (Q) at two different levels of pulmonary vascular resistance (PVR). Mean pulmonary.

Tissue Doppler imaging (TDI) of the basal part of the right ventricle free wall allows the measurements on a single cardiac cycle of several parameters.

An algorithm for investigating pulmonary hypertension (PH) using echocardiography. An algorithm for investigating pulmonary hypertension (PH) using echocardiography.

Cardiac index (CI) changes from baseline following single oral doses of riociguat (○) 1 mg and 2.5 mg compared with inhaled nitric oxide (•) in patients.

Distribution of systolic pulmonary artery pressure (Ppa) in relation to functional class (FC) for congenital heart disease patients with a) atrial septal.

Introduction; The Cardiovascular System (CVS)

Compounds acting on pathogenic pathways of pulmonary arterial hypertension. Compounds acting on pathogenic pathways of pulmonary arterial hypertension.

Effects of pulmonary capillary wedge pressure (Ppcw) and stroke volume (SV) on systolic (s), diastolic (d) and mean (m) pulmonary arterial pressures (Ppa).

Schematic drawing of PAH crisis and contributing factors.

Pathogenic concepts of pulmonary arterial hypertension (PAH).

Pulmonary artery pressure in a) healthy subjects and b) pulmonary hypertension (PH) subjects. Pulmonary artery pressure in a) healthy subjects and b) pulmonary.

A) Mean pulmonary arterial pressure (Ppa) as a function of cardiac output (Q) at constant left atrial pressure (Pla) and b) Ppa as a function of Pla at.

Cardiac index (CI) changes from baseline following single oral doses of riociguat (Rio) compared with inhaled nitric oxide (NO) in patients with chronic.

Tracing of tidal breathing followed by an inspiratory manoeuvre to total lung capacity (TLC) to record inspiratory capacity (IC), followed by a full expiration.

Presentation transcript:

Pathophysiology of right ventricular (RV) failure. Pathophysiology of right ventricular (RV) failure. Pulmonary hypertension increases RV afterload requiring a homeometric adaptation, i.e. an increased RV contractility. When this adaptation fails, the RV enlarges with increased end-diastolic volume (EDV), decreasing left ventricle preloading because of competition for space within the pericardium. This decreases stroke volume (SV) and blood pressure, with negative systolic interaction as a cause of further RV–arterial uncoupling, which may be aggravated by RV ischaemia from decreased coronary perfusion pressure (gradient between diastolic blood pressure and right atrial pressure). Obvious targets for interventions are indicated as 1 to 4. See the A global view on RV failure section for further details. iNO: inhaled nitric oxide; iILO: inhaled iloprost; PDE5i: phosphodiesterase type-5 inhibitor; ERA: endothelin receptor antagonist; PGI2: prostaglandin I2; FRC: functional residual capacity. Robert Naeije, and Alessandra Manes Eur Respir Rev 2014;23:476-487 ©2014 by European Respiratory Society